Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells.
about
A very late viral protein triggers the lytic release of SV40Interaction of the single-stranded DNA-binding protein Puralpha with the human polyomavirus JC virus early protein T-antigenSimian virus 40 large T antigen targets the spindle assembly checkpoint protein Bub1Simian virus 40 large T antigen affects the Saccharomyces cerevisiae cell cycle and interacts with p34CDC28Nuclear localization of the NS3 protein of hepatitis C virus and factors affecting the localizationInhibition of p53 DNA binding by human papillomavirus E6 proteinsp53 isoforms can regulate p53 transcriptional activity.Identification of binding sites on the regulatory A subunit of protein phosphatase 2A for the catalytic C subunit and for tumor antigens of simian virus 40 and polyomavirusRotavirus-encoded nonstructural protein 1 modulates cellular apoptotic machinery by targeting tumor suppressor protein p53Isolation and characterization of a human p53 cDNA clone: expression of the human p53 geneMDMX: a novel p53-binding protein with some functional properties of MDM2Human TAFII31 protein is a transcriptional coactivator of the p53 proteinHuman Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulatorUV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cellsThe history of tumor virology100 years of Rous sarcoma virusContagious cancerAdenovirus early region 1B 58,000-dalton tumor antigen is physically associated with an early region 4 25,000-dalton protein in productively infected cellsT antigen mutations are a human tumor-specific signature for Merkel cell polyomavirusThe first 30 years of p53: growing ever more complexExtension of the replicative life span of human diploid fibroblasts by inhibition of the p33ING1 candidate tumor suppressorSmall-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapyViruses associated with human cancerThe expanding regulatory universe of p53 in gastrointestinal cancerOncogenic Intra-p53 Family Member Interactions in Human CancersP53 functional abnormality in mesenchymal stem cells promotes osteosarcoma developmentMicrobial Regulation of p53 Tumor SuppressorCaloric restriction: is mammalian life extension linked to p53?Oncogenes and RNA splicing of human tumor virusesSmoking, p53 mutation, and lung cancerUncovering the role of p53 splice variants in human malignancy: a clinical perspectiveMatrix and backstage: cellular substrates for viral vaccinesPolyoma small T antigen triggers cell death via mitotic catastropheRegulation of protein quality control by UBE4B and LSD1 through p53-mediated transcriptionEmerging Non-Canonical Functions and Regulation by p53: p53 and StemnessThe p53 circuit boardA Cross-Cancer Genetic Association Analysis of the DNA Repair and DNA Damage Signaling Pathways for Lung, Ovary, Prostate, Breast, and Colorectal Cancer.When NRF2 talks, who's listening?p300 family members associate with the carboxyl terminus of simian virus 40 large tumor antigenParticipation of multiple factors, including proliferin, in the inhibition of myogenic differentiation
P2860
Q21559509-CECBE825-C6C7-46B1-AD7B-66862BB6CCAFQ22008057-4DBD5ACD-A889-4722-BA45-DF943C177305Q24305356-0A660598-06E8-49C8-B6EE-B79918C2C3FBQ24308996-D63FAFCA-B279-48FC-B601-4D597E33CA3EQ24310625-EE5D7E19-13F4-46C7-A2AE-2FC60A6735CFQ24317013-1F7BB31F-4B78-40B8-BC9B-91AE3BCEFB5CQ24319034-68BFCDB7-DD07-4569-BD4D-E0A915E31343Q24337360-5902801D-8120-407F-8113-6C77C06297ACQ24338301-300CFAE6-4B1A-4819-A2B6-2691EB63E4FBQ24555633-8CD1E849-6FE1-4207-AC54-52D037CC84A8Q24561971-2A2C0ED8-DC66-406B-A3A8-CCF7026DD6DBQ24562978-C517A797-BFF2-449F-B167-85E764EF16FFQ24609227-76658123-9EA5-4B35-BFFC-F468D966F6D4Q24609948-98278FDA-BDBF-4F0A-8FA9-39E972803453Q24610004-9F517535-E926-4441-9953-2208BA4E2323Q24610856-3BBE35AF-F6B1-4ABC-834B-0C4B03DBF165Q24633347-F2041491-C355-49CB-BC1F-49964D41D55FQ24643689-8259E7DD-87A5-4BBA-8258-69EDF0EF92E2Q24645091-552E0A14-4454-46C5-BE7C-08EA0381210DQ24645732-F185FD99-0986-4783-8413-9FE6F2711FBEQ24646710-1C7E3647-62E2-48B3-87CA-5F226D572C3FQ24651380-4B80E779-B410-4359-BD3A-60106409DD13Q24653900-F4BAC45C-E541-48F5-A9FB-7C49C871602AQ26742058-659CEB82-EC12-4C6F-87D6-7CF0C9A8AF11Q26749382-06F37873-88FD-4384-A677-11D51F1F2618Q26771603-F62206DF-49B8-40D0-9AD7-37E9B4D244B4Q26785743-B796B285-5AC1-45D5-837C-65F082FCF5E3Q26829232-AECACDF0-D5D4-451C-96E8-0FED24271663Q26830643-3AF69DF7-07AD-4E50-82E9-50AB2051DDE1Q27014977-0C386201-FFBE-4D53-B338-391E9FFA6AEEQ27015641-D291988F-5989-4C5A-B39C-EA5B7C49A0A4Q27025941-81BD4CFC-BDCE-468B-BEEF-0ECD57C78B79Q27310118-56FDD761-DD62-4AF3-ADE8-636D1475AF55Q27312393-F745F0AB-29FD-4BE5-B685-A0FB864AF543Q28077156-B500F98D-A23F-4030-8B8E-0A3607ECE011Q28259725-A958CA54-AF91-4769-937E-5EF34CD7200EQ28384141-A8C03DB2-6A74-4899-A249-19B674513781Q28384223-98F1B820-65AC-4593-B72B-C6C75023BBE5Q28565821-6573078F-F608-48F5-AABC-791FA316B3AAQ28594352-C3DDA28E-C192-44B8-9AEE-97349A85FA98
P2860
Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
1979年论文
@zh
1979年论文
@zh-cn
name
Characterization of a 54K dalt ...... ted embryonal carcinoma cells.
@en
type
label
Characterization of a 54K dalt ...... ted embryonal carcinoma cells.
@en
prefLabel
Characterization of a 54K dalt ...... ted embryonal carcinoma cells.
@en
P1433
P1476
Characterization of a 54K dalt ...... ted embryonal carcinoma cells.
@en
P2093
P356
10.1016/0092-8674(79)90293-9
P407
P577
1979-05-01T00:00:00Z